SSGA Luxembourg - State Street Europe Screened Enhanced Equity Fund ETF
SSGA Luxembourg - State Street Europe Screened Enhanced Equity Fund ETF Kurs - 1 Jahr
SIX SX USDWichtige Stammdaten
| Emittent | State Street Global Advisors |
| Auflagedatum | 25.11.2025 |
| Kategorie | Aktien |
| Fondswährung | EUR |
| Benchmark | MSCI Europe |
| Ausschüttungsart | Thesaurierend |
| Total Expense Ratio (TER) | 0,25 % |
| Fondsgröße | 418.769.720,33 |
| Replikationsart | Keine Angabe |
| Morningstar Rating | - |
Anlageziel SSGA Luxembourg SICAV - State Street Europe Screened Enhanced Equity Fund ETF EUR
So investiert der SSGA Luxembourg SICAV - State Street Europe Screened Enhanced Equity Fund ETF EUR: The objective of the Fund is to provide a return in excess of the performance of European equity markets. The investment policy of the Fund is to outperform the Index (or any other index determined by the Directors from time to time to represent substantially the same market as the Index) over the medium and long term. I nvestment policy will also involve screening out securities based on an assessment of their adherence to certain ESG criteria defined by the Investment Manager.
Der SSGA Luxembourg SICAV - State Street Europe Screened Enhanced Equity Fund ETF EUR gehört zur Kategorie "Aktien".
Wertentwicklung (NAV) WKN: A41ENN
| 3 Monate | 6 Monate | 1 Jahr | 3 Jahre | 5 Jahre | 2026 | |
|---|---|---|---|---|---|---|
| Performance | - | - | - | - | - | +2,44 % |
| Outperformance ggü. Kategorie | - | - | - | - | - | -0,17 % |
| Max Verlust | - | - | - | - | - | - |
| Kurs | - | - | - | - | - | 10,70 € |
| Hoch | - | - | 10,45 € | - | - | - |
| Tief | - | - | 10,00 € | - | - | - |
Kennzahlen ISIN: LU3121015567
| Name | 1 Jahr | 3 Jahre | 5 Jahre | 10 Jahre |
|---|---|---|---|---|
| Volatilität | ||||
| Sharpe Ratio |
Zusammensetzung WKN: A41ENN
Größte Positionen ISIN: LU3121015567
| Name | ISIN | Marktkapitalisierung | Gewichtung |
|---|---|---|---|
| ASML Holding NV | NL0010273215 | 456.671.531.190 € | 2,94 % |
| AstraZeneca PLC | GB0009895292 | 242.657.033.487 € | 2,29 % |
| Novartis AG Registered Shares | CH0012005267 | 237.845.227.364 € | 2,22 % |
| Roche Holding AG | CH0012032048 | 300.453.188.818 € | 1,91 % |
| SAP SE | DE0007164600 | 225.349.615.829 € | 1,90 % |
| HSBC Holdings PLC | GB0005405286 | 243.663.376.743 € | 1,66 % |
| Siemens AG | DE0007236101 | 198.499.211.971 € | 1,63 % |
| Nestle SA | CH0038863350 | 198.670.781.787 € | 1,58 % |
| Banco Santander SA | ES0113900J37 | 153.751.767.729 € | 1,39 % |
| UBS Group AG Registered Shares | CH0244767585 | 125.825.343.147 € | 1,35 % |
| Summe Top 10 | 18,87 % | ||
Weitere ETFs auf MSCI Europe
| ETF | TER | Größe | Perf 1J |
|---|---|---|---|
| SSGA Luxembourg SICAV - State Street Europe Screened Enhanced Equity Fund ETF EUR | 0,25 % | 418,77 Mio. € | - |
| iShares Core MSCI Europe UCITS ETF EUR (Acc) | 0,12 % | 13,93 Mrd. € | +17,52 % |
| Amundi Index Solutions - Amundi Core MSCI Europe UCITS ETF DR EUR | 0,12 % | 6,98 Mrd. € | +17,47 % |
| JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity Active UCITS ETF - EUR (acc) | 0,23 % | 2,83 Mrd. € | +16,82 % |
| Deka MSCI Europe UCITS ETF | 0,30 % | 1,33 Mrd. € | +17,18 % |